Braveheart Bio, Inc. (NASDAQ:BRVE) IPO
IPO
Priced at US$18.00 a share on Aug 5, 2026.
- Price
- US$18.00 a share
- Shares offered
- 21,250,000 shares of common stock
- Offering size
- US$382.5 million
- Underwriters' option
- Up to 3,187,500 more shares
- Listing
- BRVE on the Nasdaq Global Market
- Underwriters
- Goldman Sachs & Co. LLC, Jefferies, TD Cowen, Stifel, Cantor · In the order on the cover
- Shares delivered
- On or about Aug 7, 2026
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Apr 29, 2026 |
| Filed publicly | Jul 15, 2026 |
| Amended once | Jul 30, 2026 |
| Shares registered with an exchange | Aug 3, 2026 |
| Declared effective by the SEC | Aug 5, 2026 |
| Final prospectus, with the price | Aug 6, 2026 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Aug 6, 2026 |
| CERT · Exchange's certificate of listing | Aug 6, 2026 |
| EFFECT · Notice that a registration is effective | Aug 5, 2026 |
| S-1MEF · Registration of more shares for the same offering | Aug 5, 2026 |
| 8-A12B · Registration of shares for listing on an exchange | Aug 3, 2026 |
| S-1/A · Registration statement, amended | Jul 30, 2026 |
| S-1 · Registration statement | Jul 15, 2026 |
| DRS/A · Draft registration statement, amended | Jun 8, 2026 |
| DRS · Draft registration statement | Apr 29, 2026 |
From the cover of the final prospectus (424B4) filed Aug 6, 2026